Bristol-Myers, Roche and Merck are each working on a potential blockbuster "immunotherapy" drug that would use the body's immune system to fight advanced melanoma. Astra has an earlier-stage candidate.
from WSJ.com: US Business http://ift.tt/1nRZgLD
via IFTTT
from WSJ.com: US Business http://ift.tt/1nRZgLD
via IFTTT
No comments:
Post a Comment